Association of Nonalcoholic Fatty Liver Disease With Insulin Resistance
- 1 November 2003
- journal article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 37 (5), 399-402
- https://doi.org/10.1097/00004836-200311000-00010
Abstract
Nonalcoholic fatty liver disease (NAFLD) is frequently associated with type 2 diabetes mellitus, obesity, and dyslipidemia. We tested the hypothesis that there may be an association between NAFLD and insulin resistance (IR); and its correlation with glucose tolerance status of subjects who aren't known patients with diabetes. One hundred and seventy-six consecutive patients with elevated serum aminotransferase levels and bright liver were evaluated. Sixty-two patients were excluded from the study. Age, gender, height, weight, body mass index, waist circumferences, and family history of diabetes were recorded. Fasting plasma glucose, insulin, lipid profile were measured. A standard oral glucose tolerance test (OGTT) was performed and the index of IR was calculated according to the HOMA method. Patients with a normal glucose tolerance formed group 1 (64 patients) and patients with impaired or diabetic glucose tolerance group 2 (50 patients). Age, female sex, family history of type 2 diabetes, fasting insulin, fasting plasma glucose and HOMA-R index were statistically significantly different between the groups. Although the subjects in the study are not known patients with diabetes, the prevalence of impaired or diabetic glucose tolerance was prominent. In conclusion, performing OGTT in cases with nonalcoholic fatty liver disease may be useful for early screening of diabetes mellitus.Keywords
This publication has 23 references indexed in Scilit:
- Management of Nonalcoholic SteatohepatitisJournal of Clinical Gastroenterology, 2002
- Nonalcoholic Fatty Liver DiseaseNew England Journal of Medicine, 2002
- NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndromeHepatology, 2002
- Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteriaThe Lancet, 1999
- Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.Diabetes Care, 1999
- Metabolic Risk Factors Worsen Continuously across the Spectrum of Nondiabetic Glucose Tolerance: The Framingham Offspring StudyAnnals of Internal Medicine, 1998
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998
- Impaired Glucose Tolerance, Diabetes, and Cardiovascular Disease Risk Factor Profiles in the Elderly: The Honolulu Heart ProgramDiabetes Care, 1996
- Nonalcoholic steatohepatitis: A study of 49 patientsHuman Pathology, 1989
- Role of Insulin Resistance in Human DiseaseDiabetes, 1988